Parenteral inotropic therapy in the home: An update for home care and hospice

Home Healthcare Nurse

Volumn 31, Issue 4, 2013, Pages 190-204

  Lyons, Margaret G ^a   Carey, Lawrence ^b  

^a VILLANOVA UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT;

HEART FAILURE; HOME CARE; HOSPICE CARE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; PROCEDURES;

ADVANCE CARE PLANNING; CARDIOTONIC AGENTS; HEART FAILURE; HOME HEALTH NURSING; HOSPICE CARE; HUMANS; INFUSIONS, INTRAVENOUS; PRACTICE GUIDELINES AS TOPIC;

EID: 84876473082     PISSN: 0884741X     EISSN: 15390713     Source Type: Journal    
DOI: 10.1097/NHH.0b013e3182885f77     Document Type: Article

References (48)

1. Aiken, L. H., Clarke, S. P., Cheung, R. B., Sloane, D. M., & Silber, J. H. (2003). Educational levels of hospital nurses and surgical patient mortality. Journal of the American Medical Association, 290(12), 1617-1623.
2. Albert, N. M. (2012). Fluid management strategies in heart failure. Critical Care Nurse, 32, 20-32. doi:10.4037/ccn2012877
3. American Nurses' Credentialing Center (ANCC). (n.d.). ANCC Magnet Recognition Program. Retrieved from http://www.nursecredentialing.org/Magnet. aspx
4. Assad-Kottner, C., Chen, D., Jahanyar, J., Cordova, F., Summers, N., Loebe, M., ..., Torre-Amione, G. (2008). The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times. Journal of Cardiac Failure, 14(10), 839-843. doi:10.1016/j.cardfail.2008.08.004
5. Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE). (2002). Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 117(21), e350-e408.
6. Berg, A. M., Snell, L., & Mahle, W. T. (2007). Home inotropic therapy in children. Journal of Heart and Lung Transplantation, 26, 453-457. doi:10.1016/j.healun.2007.02.004
7. Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A, ..., Liu, P. P. (2006). Outcome of heart failure with preserved ejectionfraction in a populationbased study. New England Journal of Medicine, 355(3), 260-269.
8. Bolli, R., Chugh, A., Loughran, J., Kajstura, J., & Anversa, P. (2012). Cardiac stem cells in patients with ischaemic cardiomyopathy: Authors' reply. Lancet, 379(9819), 891-892. doi:10.1016/S0141-6736(12)60387-0
9. Caldwell, J. C., & Mamas, M. A. (2012). Heart failure, diastolic dysfunction and atrial fibrillation: Mechanistic insight of a complex inter-relationship. Heart Failure Review, 17(1), 27-33.
10. Centers for Disease Control and Prevention. (n.d.a). Heart failure fact sheet. Retrieved from http://www.cdc.gov/DHDSP/data-statistics/fact-sheets/fs- heart-failure.htm
11. Centers for Medicare and Medicaid Services [CMS]. (n.d.b). Your medicare benefits. Retrieved from http://www.medicare.gov/publications/pubs/pdf/10116.pdf
12. Centers for Medicare and Medicaid Services [CMS]. (n.d.c). Medicare hospice benefits. Retrieved from http://www .medicare.gov/publications/pubs/pdf/ 02154.pdf
13. Coviello, J. (2009). Heart failure: An update. Home Healthcare Nurse, 27(6), 355-361.
14. Craven, H. (2007). Recognizing excellence: Unit-based activities to support specialty nursing certification. MedSurg Nursing, 16(6), 367-371.
15. Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., Freedman, R. A., Gettes, L. S., ..., Sweeney, M. O. (2008, May 27). ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 117(21), e350-e408.
16. Gheorghiade, M., & Filippatos, G. (2005). Reassessing treatment of acute heart failure syndromes: The ADHERE Registry. European Heart Journal, 7(suppl.B), B13-B19.
17. Goldfinger, J. Z., & Adler, E. D. (2010). End-of-life options for patients with advanced heart failure. Current Heart Failure Reports, 7, 140-147. doi:10.1007/s11897-010-0017-5
18. Gorski, L. (2005). Discharge planning for the patient requiring home infusion therapy. Topics in Advanced Practice Nursing eJournal [Series on the Internet], 5(3). Retrieved from http://www.medscape.com
19. Hauptman, P. J., Mikolajczak, P., George, A., Mohr, C. J., Hoover, R., Swindle, J., & Schnizler, M. A. (2006). Chronic inotrpoic therapy in end-stage heart failure. American Heart Journal, 152(6), 1096.e1-1098.e1. doi:10.10161/j.ahj2006.08.003
20. Heart Failure Society of America. (2010). Executive summary: HFSA 2010 comprehensive heart failure practice guideline. Journal of Cardiac Failure, 16(6), 475-539.
21. Hunt, S. A., American College of Cardiology, & American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and management of Heart Failure). Journal of the American College of Cardiology, 46(6), e1-e82.
22. Infusion Nurses Society [INS]. (2011). Infusion nursing standards of practice. Journal of Infusion Nursing, 34(1S), S1-S110.
23. Infusion Nurses Society [INS]. (n.d.). Clinical nursing forum answers. Retrieved from http://knowledge .ins1.org/expert-forum.php
24. Jaski, B. E., Jessup, M. L., Mancini D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., ..., Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators. (2009). Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. Journal of Cardiac Failure, 15(3), 171-181.doi:10.1016/j.cardfail.2009.01.013
25. Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S. Ganiats, T. G., ..., Stevenson, L. W. (2009). 2009 Focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults - A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Journal of the American College of Cardiology, 53, 1343-1382. doi:10.1016/j.jacc.2008.11.009
26. Kato, M., Stevenson, L. W., Palardy, M., Campbell, P. M., May, C. W., Lakdawala, N. K., ..., Setoguchi, S. (2012). The worst symptom as defined by patients during heart failure hospitalization: Implications for response to therapy, Journal of Cardiac Failure, 18(7), 524-533.
27. Kazory, A., & Ross, E. A. (2012). Emerging therapies for heart failure: Renal mechanisms and effects. Heart Failure Review, 17, 1-16. doi:10.1007/s10741-010-9191-5
28. Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., ..., Rosamond, W. D. (2010). Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Circulation, 121(4), 586-613.
29. McPherson, C. A., & Manthous, C. (2004). Permanent pacemakers and implantable defibrillators: Considerations for intensivists. American Journal of Respiratory Critical Care Medicine, 170, 933-940, doi:10.1164/rccm.200402-211UP
30. National Home Infusion Association [NHIA]. (2011). Phase I: 2010 NHIA Provider Survey: Comprehensive Aggregate Analysis Report. Alexandria, Virginia.
31. National Home Infusion Association [NHIA]. (2012). NHIA testimony to the House Ways and Means Subcommittee on Health related to the June 19, 2012 hearing on the Medicare Payment Advisory Commission's (MedPAC's) June 2012 Report to Congress. Retrieved from http://nhia.org/documents/06 292012MedPACreportHIT.pdf
32. National Institute for Health and Clinical Excellence. (2010). Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. Retrieved from http://guidance.nice.org.uk/CG108/NICEGuidance/ pdf/English
33. National Prevention, Health Promotion and Public Health Council. (2011, June). National prevention strategy: America's plan for better health and wellness. Retrieved from http://www.healthcare.gov/prevention/nphpphc/index.html
34. O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., ..., Califf, R. M. (2011). Effect of nesiritide in patients with acute decompensated heart failure. New England Journal of Medicine, 365(1), 32-43. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/ 21732835. doi:10.1056/NEJMoa1100171. PMID 21732835.
35. Owan, T. E, Hodge, D. O. Herges, R. M., Jacobsen, S. J., Roger V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heartfailure with preserved ejection fraction. New England Journal of Medicine, 355(3), 251-259.
36. RegistriesLive.org. (n.d.). Acute Decompensated Heart Failure National Registry (ADHERE). Retrieved from http://www.registrieslive.org/RegistryDetails. aspx?qRegDetID=217
37. Rodgers, J. E., & Lee, C. R. (2011). Acute decompensated heart failure. In J. T. DiPiro, R. L. Talbert, C. G. Yee, et al. (Eds.), Pharmacotherapy: A pathophysiologic approach (8th ed., pp. 191-208). New York: McGraw Hill.
38. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., ..., Turner, M. B. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2012). Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation, 125, e2-e220. doi:10.1161/CIR.0b013e31823ac046
39. Rosa, M. A. (2008). How a heart failure home care disease management program makes a difference. Home Healthcare Nurse, 26(8), 483-490.
40. Schocken, D. D., Benjamin, E., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., ..., Functional Genomics and Translational Biology Interdisciplinary Working Group. (2008). Prevention of heartfailure: A scientific statement from the American Heart AssociationCouncils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 117, 2544-2565.
41. Sommers, A., & Cunningham, P. J. (2011). Physician visits after hospital discharge: Implications for reducing readmissions. National Institute for Health Care Reform, Research Brief, No. 6. Retrieved from http://www.nihcr.org/Reducing-Readmissions.html
42. Stone, J., & Hoffman, G. J. (2010, September 21). Medicare hospital readmissions: Issues, policy options and the PPACA. Congressional Research Service (CRS) Report R40972. Retrieved from www.crs .gov.1-37
43. Stuart, B. (2007). Palliative care and hospice in advanced heart failure. Journal of Palliative Medicine, 10(1), 210-228. doi:10.1089/jpm.2008.9988
44. Taitel, M., Meaux, N., Pegus, C., Valerian, C., & Kirkham, H. (2012). Place of death among patients with terminal heart failure in a continuous inotropic infusion program. American Journal of Hospice and Palliative Medicine, 29(4), 249-253.
45. Teerlink, J. R., Metra, M., Zaca, V., Sabbah. H. N., Cotter, G., Gheorghiade, M., & Cas, L. D. (2009). Agents with inotropic properties for the management of acute heart failure syndromes: Traditional agents and beyond. Heart Failure Review, 14(4), 243-253.
46. The Criteria Committee of the New York Heart Association (NYHA). (1994). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels (9th ed., pp. 253-256). Boston, MA: Little, Brown.
47. Zacharias, H., Raw, J., Nunn, A., Parsons, S., & Johnson, M. (2011). Is there a role for subcutaneous furosemide in the community and hospice management of endstage heart failure? Palliative Medicine, 25, 658-663. doi:10.1177/0269216311399490
48. Zarychanski, R., Ariano, R. E, Paunovic, B., & Bell, D. D. (2009). Historical perspectives in critical care medicine: Blood transfusion, intravenous fluids, inotropes/vasopressors, and antibiotics. Critical Care Clinics, 25(1), 201-220. doi:10.1016/j.ccc.2008.10.003